Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02298348 |
| Title | Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma |
| Acronym | N2013-02 |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | New Approaches to Neuroblastoma Therapy Consortium |
| Indications | |
| Therapies | |
| Age Groups: | adult | child |
| Covered Countries | USA | CAN |